Mustang Bio, Inc. MBIO
Set alert
0.42 USD +0.01 +3.72%
At close · Nov 2
0.42 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
0.4002 Day range 0.4264
0.35 52-week range 1.45
- YTD
- -57.70%
- 1 year
- -71.38%
- Open
- 0.4009
- Prev close
- 0.4001
- Mkt cap
- 3.14M
- Vol
- 34.15K
- Avg vol
- 31.23K
- EPS
- -0.46
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.4002
- High
- 0.4264
- Forward P/E
- -0.47
- Beta
- 0.00
- Short ratio
- 0.22
- Inst. own
- 5.72%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.22622
- 200-d avg
- 0.369385
- 1y target
- 0.00
MAX chart
Events in this range
- Apr 4, 2023Split: 1 for 15
- Aug 14, 2023Earnings: -2; estimate -2.07; surprise 3.38%
- Aug 15, 2023Rating: HC Wainwright & Co. · Buy → Buy
- Aug 15, 2023Rating: BTIG · Buy → Buy
- Aug 16, 2023Rating: HC Wainwright & Co. · Buy → Buy
- Aug 24, 2023Rating: Cantor Fitzgerald · Overweight → Overweight
- Nov 14, 2023Earnings: -1.23; estimate -1.88; surprise 34.57%
- Mar 11, 2024Earnings: -0.71; estimate -1.68; surprise 57.74%
- May 13, 2024Rating: HC Wainwright & Co. · Buy → Buy
- May 15, 2024Earnings: -0.46; estimate 0; surprise —%
- May 16, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Aug 13, 2024Earnings: -0.24; estimate -0.14; surprise -71.43%
- Nov 8, 2024Earnings: -0.04; estimate -0.13; surprise 69.23%
- Jan 16, 2025Split: 1 for 50
Signals (154)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 26, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 19, 2026 | 2 weeks ago |
| RSI: Oversold | Oct 5, 2026 | 4 weeks ago |
| SMA: Bearish | Jul 13, 2026 | 3 months ago |
| SMA: Bullish | Jun 22, 2026 | 4 months ago |
| SMA: Bearish | Jun 15, 2026 | 4 months ago |
| SMA: Bullish | Jun 8, 2026 | 4 months ago |
| SMA: Bearish | Mar 2, 2026 | 8 months ago |
| SMA: Bullish | Feb 23, 2026 | 8 months ago |
| SMA: Bearish | Oct 27, 2025 | 1 year ago |
| SMA: Bullish | Sep 8, 2025 | 1 year ago |
| SMA: Bearish | Aug 18, 2025 | 1 year ago |
| SMA: Bullish | Aug 4, 2025 | 1 year ago |
| SMA: Bearish | Jul 28, 2025 | 1 year ago |
| SMA: Bullish | Jun 30, 2025 | 1 year ago |
| SMA: Bearish | Jun 9, 2025 | 1 year ago |
| RSI: Oversold | Jun 9, 2025 | 1 year ago |
| RSI: Oversold | Feb 24, 2025 | 1 year ago |
| SMA: Bearish | Jan 13, 2025 | 1 year ago |
| SMA: Bullish | Dec 30, 2024 | 1 year ago |
Newest 20 of 154.
Financial health
Altman Z-Score
-35.77 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 4
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 5
Valuation
P/E -2.5×
FY 2016 5y median -11.3× FY 2025
P/S 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 0.5×
FY 2016 5y median 44.1× FY 2025
P/FCF -0.9×
FY 2016 5y median -11.7× FY 2025
EV/EBITDA 6.6×
FY 2016 5y median -12.0× FY 2025
EV/Sales 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -109.3%
FY 2016 5y median -8.5% FY 2025
Profitability
Gross Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -20.2%
FY 2016 5y median -59.0% FY 2025
ROIC -25.1%
FY 2016 5y median -58.2% FY 2025
ROA -10.9%
FY 2016 5y median -83.9% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2016 FY 2025
Operating Income 85.0%
FY 2016 FY 2025
EPS (diluted) 84.8%
FY 2016 FY 2025
Free Cash Flow 53.9%
FY 2016 FY 2025
Financial Health
Current Ratio 2.2×
FY 2016 5y median 2.2× FY 2025
Quick Ratio 2.2×
FY 2016 5y median 2.2× FY 2025
Debt / Equity 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 9.2×
FY 2016 5y median 0.6× FY 2025
Interest Coverage 0.0×
FY 2016 5y median -22.7× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
